Company Analysis

HUTCHMED (China) Limited (HCM)

Nasdaq: HCM · Pharmaceutical Preparations · Hong Kong · filing with the SEC since 2015
Grade6.0
◀ Past 7.0● Present 6.7▶ Future 4.0
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 5, 2026Mar 19, 2025Feb 28, 2024Feb 28, 2023Mar 3, 2022Mar 4, 2021Mar 3, 2020Mar 11, 2019Mar 12, 2018Mar 13, 2017
Revenue548,512630,201837,999426,409356,128227,976204,890214,109241,203216,080
Cost of revenue336,349348,884384,447311,103····169,764149,132
Research and development148,295212,109302,001386,893299,086174,776138,190114,16175,52366,871
General and administrative66,72264,29679,78492,17389,29850,01539,21030,90923,95521,580
Total operating expenses·········262,777
Total costs and expenses587,672673,906819,624834,102684,445424,644351,276306,750294,620262,777
Operating income-39,160-43,70518,375-407,693-328,317-196,668-146,386-92,641-53,417-46,697
Interest expense2,8652,8727596525927871,0301,0091,4551,631
Interest and investment income49,87740,08036,1459,5992,0763,2364,9445,9781,220502
Share of profit of equity-method investments22,65146,46947,29549,75360,61779,04640,70019,33333,65366,244
Other income (expense), net·········-139
Total non-operating income (expense)60,95542,59839,933-2,729-8,7336,9345,2815,986-119-659
Income before income taxes498,691-1,10758,308-410,422-215,740-189,734-141,105-86,655-53,536-47,356
Income tax expense63,6107,1924,509-28311,9184,8293,2743,9643,0804,331
Income from continuing operations·········11,698
Net income including non-controlling interests457,73238,170101,094-360,386-167,041-115,517-103,679-71,286-22,96314,557
Net income to non-controlling interests82344131444927,60710,2132,3453,5193,7742,859
Net income456,90937,729100,780-360,835-194,648-125,730-106,024-74,805-26,73711,698
Net income to common shareholders········-26,73711,698
Earnings per share, basic0.530.040.12-0.43-0.25-0.18-0.16-0.11r-0.04r0.20
Earnings per share, diluted0.520.040.12-0.43-0.25-0.18-0.16-1.13-0.430.20
Earnings per share, basic and diluted·····-0.18-0.16-0.11-0.04·
Weighted average shares, basic858,276,608855,351,683849,654,296847,143,540792,684,524697,931,437665,683,145664,263,820r617,171,710r59,715,173
Weighted average shares, diluted872,891,120872,829,129869,196,348847,143,540792,684,524697,931,437665,683,14566,426,38261,717,17159,971,050
Weighted average shares, basic and diluted·····697,931,437665,683,145664,263,820617,171,710·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
us-gaap:SalesRevenueNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton HCM · research, not advice